Neumora (NASDAQ: NMRA) COO sells 176K shares, awarded 200K options
Rhea-AI Filing Summary
For Neumora Therapeutics, Inc. (NMRA), Chief Operating and Development Officer Aurora Daljit Singh reported multiple option exercises, share sales, and a new option grant. On August 20–21, 2026, Singh (and an affiliated family trust) exercised options to acquire a total of 176,060 shares of common stock at an exercise price of $0.72 per share and sold 176,060 shares in open-market transactions at weighted average prices around $1.51–$1.64 per share, including sales by the Aurora Family Trust, whose beneficiaries are immediate family members.
Separately, on August 20, 2026, Singh received a grant of 200,000 stock options with an exercise price of $1.52 per share, expiring on August 20, 2036. According to the vesting terms, 25% of these options vest on the first anniversary of August 20, 2026, and the remainder vest in equal monthly installments over the following three years.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 176,060 shares ($143K approx. pre-tax spread)
Exercise and Sale
15 txns
Insider
Aurora Daljit Singh
Role
See Remarks
Sold
176,060 shs ($270K)
Approx. gross sale proceeds
$270K
Approx. exercise cost
$127K
Approx. pre-tax spread
$143K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F4 | 20,553 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 21,055 | $0.00 | $0.00 |
| Exercise | Common Stock | 20,553 | $0.72 | $15K |
| Sale | Common Stock F7 | 20,553 | $1.5949 | $33K |
| Exercise | Common Stock F3 | 21,055 | $0.72 | $15K |
| Sale | Common Stock F8, F3 | 21,055 | $1.5958 | $34K |
| Exercise | Stock Option (Right to Buy) F4 | 67,741 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 45,026 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5, F3 | 21,685 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) F6 | 200,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 67,741 | $0.72 | $49K |
| Sale | Common Stock F1 | 67,741 | $1.5144 | $103K |
| Exercise | Common Stock F3 | 21,685 | $0.72 | $16K |
| Exercise | Common Stock F3 | 45,026 | $0.72 | $32K |
| Sale | Common Stock F2, F3 | 66,711 | $1.514 | $101K |
Holdings After Transaction:
Stock Option (Right to Buy) — 94,798 shares (Indirect, See footnote);
Stock Option (Right to Buy) — 288,974 shares (Direct);
Common Stock — 48,750 shares (Direct);
Common Stock — 0 shares (Indirect, See footnote)
Footnotes (8)
- F1. This transaction was executed in multiple trades at prices ranging from $1.485 to $1.625, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F2. This transaction was executed in multiple trades at prices ranging from $1.48 to $1.6252, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F3. Shares held by Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.
- F4. 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F5. The stock option is fully vested and exercisable.
- F6. 25% of the shares subject to the option vest on the first anniversary measured from August 20, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F7. This transaction was executed in multiple trades at prices ranging from $1.51 to $1.6379, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F8. This transaction was executed in multiple trades at prices ranging from $1.51 to $1.6393, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Key Figures
Shares sold: 176,060 shares
Options exercised: 176,060 shares
Option exercise price: $0.72 per share
+4 more
7 metrics
Shares sold
176,060 shares
Total NMRA common shares sold across reported transactions on August 20–21, 2026
Options exercised
176,060 shares
Total underlying NMRA shares from options exercised (codes M) per transaction summary
Option exercise price
$0.72 per share
Exercise price for multiple stock options converted into NMRA common stock
Weighted average sale prices
$1.5144, $1.5140, $1.5949, $1.5958 per share
Reported weighted average prices for four NMRA sale transactions
New option grant
200,000 stock options
Options on NMRA common stock granted August 20, 2026 to Aurora Daljit Singh
New option exercise price
$1.52 per share
Exercise price of the 200,000-option grant expiring August 20, 2036
New option expiration
August 20, 2036
Expiration date of the 200,000 newly granted NMRA stock options
Key Terms
Stock Option (Right to Buy), weighted average sale price, Aurora Family Trust, Vesting Commencement Date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
weighted average sale price financial
"The price reported in Column 4 above reflects the weighted average sale price."
Aurora Family Trust financial
"Shares held by Aurora Family Trust, of which members of the Reporting"
Vesting Commencement Date financial
"measured from August 20, 2026 (the "Vesting Commencement Date"), and 1/48th"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
indirect ownership financial
"ownership_type: "indirect", nature_of_ownership: "See footnote""
FAQ
What insider transactions did Aurora Daljit Singh report for NMRA on August 20–21, 2026?
Aurora Daljit Singh reported exercising options for 176,060 shares of Neumora Therapeutics common stock at $0.72 per share and selling 176,060 shares in open-market transactions at weighted average prices of about $1.51–$1.64 per share over August 20–21, 2026.
What new stock options did Aurora Daljit Singh receive from Neumora Therapeutics (NMRA)?
On August 20, 2026, Singh received a grant of 200,000 stock options for NMRA common stock with an exercise price of $1.52 per share, expiring on August 20, 2036, as reported in the Form 4.
How do the newly granted NMRA options to Aurora Daljit Singh vest?
For the 200,000 newly granted NMRA options, 25% vest on the first anniversary of August 20, 2026. The remaining options vest in monthly installments over the next three years, so that 100% are vested on the fourth anniversary.
At what prices did Aurora Daljit Singh sell NMRA common stock?
Reported NMRA stock sales were executed in multiple trades at prices ranging from about $1.48–$1.64 per share. The Form 4 states weighted average sale prices of $1.5144, $1.5140, $1.5949, and $1.5958 per share for the respective sale transactions.
Were the NMRA option exercises and sales on August 20–21, 2026 net-buy or net-sell for Aurora Daljit Singh?
Across the reported August 20–21, 2026 transactions in NMRA, Singh’s activity reflects a net-sell position of 176,060 shares based on the Form 4’s transaction summary, which aggregates all buy and sell activity for the period.
AI-generated analysis. How Rhea-AI works. Not financial advice.
